Curidium Joins the Personalized Medicine Coalition
Curidium Medica plc has announced that it has joined the US-based Personalized Medicine Coalition.
eXludus Joins BioIT Alliance to Speed Life Sciences Research on Clusters and Grids
eXludus will contribute leadership in accelerating time-to-discovery through processing of biomedical applications and data across clusters and Grids.
Guardian Technologies Forms new Applied Visual Sciences Healthcare Subsidiary
The new subsidiary will be focused on accelerating the commercialization of the Company’s disease detection technology for the healthcare industry.
Studies Confirm Rise of HIV Variant Strains in the United States and Importance of Reliable Viral Load Testing
According to Abbott, with the US launch of their RealTime HIV-1 viral load test physicians now have a reliable test to help ensure that their patients are receiving the most effective treatment.
Improved Prediction of Prostate Cancer Recurrence through Systems Pathology
Aureon Laboratories and their collaborators publish their 'Systems Pathology' model for predicting prostate cancer PSA recurrence in the Journal of Clinical Investigation.
Personalized Medicine: Milestone in the Therapy Control of Humanized Antibodies
CENiMED, BioTeZ and Invitek announce their cooperation to develop, produce and market the Recovery-ELISAs for the therapy control of humanized antibodies.
Abbott Announces Termination of Contract with GE
Abbott and GE have mutually agreed to terminate their contract for the sale of Abbott’s core laboratory and point-of-care diagnostics businesses to GE.
EMBL Expands to Australia
Delegates representing the 19 member states of the EMBL offered Australia associate membership in EMBL’s international community.
Canadian Scientists Identify Chromosome Linked to Colorectal Cancer
Researchers at the Ontario Institute for Cancer Research have identified a genetic variation on chromosome 8 associated with colorectal cancer.
Roche Completes Acquisition of BioVeris
Roche Diagnostics now owns the patents for Electrochemiluminescence technology and can expand its immunochemistry into new market segments.